International Clinical Trial: Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826910) titled 'Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine' on Sept. 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Konrad Peter Weber

Condition: Migraine Disorders, Brain Healthy Adult Participants Vestibulo-Ocular Reflex

Intervention: Drug: Atogepant 60 mg

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: January 1, 2027

Target Sample Size: 80

Coun...